Results 221 to 230 of about 127,985 (250)
Some of the next articles are maybe not open access.

RSV-Protect

2021
Respiratory syncytial virus (RSV) causes severe respiratory tract infections in infants and elderly. Without antiviral therapies there is an urgent need for a RSV vaccine. Based on an exploratory study in non-human primates (NHP) and the importance of tissue-resident memory T cells for rapid mucosal immune responses the project aims to confirm the ...
openaire   +1 more source

Comparative study of RSV rescue from RSV‐transformed mammalian cells

International Journal of Cancer, 1971
AbstractAll individual heterokaryons obtained by fusion of cells of the five different mammalian RSV‐transformed virogenic cells with indicator chicken fibroblasts produced infectious RSV. In contrast, non‐virogenic mammalian cells derived from tumours which arose in mice injected with RSV did not give rise to infectious RSV, even when fused with ...
J, Svoboda   +3 more
openaire   +2 more sources

Health economics and RSV

Paediatric Respiratory Reviews, 2009
An economic analysis was performed in Spain to evaluate the efficiency (cost-effectiveness) of palivizumab in preventing severe RSV infection in premature infants with GA 32-35 and two or more risk factors (RF). The design was a decision tree model using data from the scientific literature and the FLIP I and FLIP II studies IRIS Study Group.
Xavier, Carbonell-Estrany   +1 more
openaire   +2 more sources

1983 Brussel ‘nekt’ RSV

2022
Item does not contain ...
Kroeze, D.B.R., Keulen, S.
openaire   +2 more sources

RSV

2023
Markus Knuf, Bernd Salzberger
openaire   +1 more source

RSV

2009
Christian G. Bien   +79 more
openaire   +1 more source

RSV-Bronchiolitis

Monatsschrift Kinderheilkunde, 2005
G. D�ring   +3 more
openaire   +1 more source

RSV's identity crisis

The Lancet Infectious Diseases, 2007
openaire   +2 more sources

RSV-​Update

Pädiatrie & Pädologie, 2022
openaire   +1 more source

Home - About - Disclaimer - Privacy